Literature DB >> 35855704

Study of angiogenesis in invasive breast carcinoma by morphometry and immunohistochemistry.

J K Bhatia1, Tripta Chaudhary2, Dibyajyoti Boruah3, Reena Bharadwaj4.   

Abstract

Background: Breast cancer is the leading cause of cancer-related deaths in Asia and is emerging as the commonest female malignancy. Angiogenesis or neovascularization is important for the growth and spread of malignant tumors, and quantitative assessment of angiogenesis may prove valuable in prognostication. This study was undertaken to quantify and explore angiogenesis with immunohistochemistry with CD 34, CD 105, and vascular endothelial growth factor (VEGF), as well as morphometric analysis and correlate with the grades of the invasive breast carcinoma.
Methods: Angiogenesis was assessed by morphometry and immunohistochemistry. Seventy cases of invasive ductal carcinoma (IDC) and twenty-five benign cases as controls were included in the study. Morphometry was performed on the CD34 and CD105 (Endoglin) stained representative histologic sections with the use of a computerized digital photomicrograph system using image analyzing software. Morphometric analysis and evaluation of vascular parameters, i.e. microvessel density (MVD), microvessel caliber (VC), and total microvessel boundary density (TVBD), were calculated. Semiquantitative assessment of angiogenesis of VEGF-stained sections was done by scoring. Immunohistochemical staining was correlated with the histological grade of the tumors. MVD, mean VC, TVBD with their mean values, SD, and range were calculated using Statistical Package for The Social Sciences (Version 20). One-way analysis of variance (ANOVA) with Tukey HSD was performed to assess the difference of the parameters for the groups. Spearman rank correlation coefficients ρ were calculated.
Results: The vascular parameters were significantly more in malignant lesions as compared to benign lesions and showed differences with increasing grade. Grades of breast carcinoma showed a mild positive correlation with VEGF (ρ = 0.467), MVD-CD34 (ρ = 0.422) and VC-CD34 (ρ = 0.482); and moderate positive correlation with TVBD-CD34 (ρ = 0.615), VC-CD105 (ρ = 0.527), and TVBD-CD105 (ρ = 0.354). When these parameters were compared with each other for all four groups, VEGF showed a mild positive correlation with MVD-CD34 (ρ = 0.295), TVBD-CD34 (ρ = 0.339), and TVBD-CD105 ((ρ = 0.277). MVD-CD105 showed a mild positive correlation with MVD-CD34 TVBD-CD105 also showed a strong positive correlation with MVD-CD34. VC-CD105 showed a moderate positive correlation with VC-CD34. CD 105 stained fewer but larger caliber vessels. Conclusions: In this study, vascular parameters showed significant differences in three grades of IDC with CD34. Differences were seen in vascular parameters stained with CD105 in three grades of IDC. Expression of VEGF also showed significant differences with positive correlations in the three grades of IDC. CD34 highlighted both old and newly formed microvessels. CD 105 stained fewer but larger caliber microvessels. VC-CD105 can be an extremely useful adjunct along with VEGF and CD34 to study angiogenesis of vessels in IDC.
© 2021 Director General, Armed Forces Medical Services. Published by Elsevier, a division of RELX India Pvt. Ltd.

Entities:  

Keywords:  Angiogenesis (neovascularization); Endoglin (CD105); Immunohistochemistry; Invasive ductal carcinoma; Vascular endothelial growth factor

Year:  2021        PMID: 35855704      PMCID: PMC9287664          DOI: 10.1016/j.mjafi.2021.10.013

Source DB:  PubMed          Journal:  Med J Armed Forces India        ISSN: 0377-1237


  30 in total

1.  Immunohistochemical measurement of tumor vascular endothelial growth factor in breast cancer. A more reliable predictor of tumor stage than microvessel density or serum vascular endothelial growth factor.

Authors:  G Callagy; E Dimitriadis; J Harmey; D Bouchier-Hayes; M Leader; E Kay
Journal:  Appl Immunohistochem Mol Morphol       Date:  2000-06

2.  Incidence and Mortality and Epidemiology of Breast Cancer in the World.

Authors:  Mahshid Ghoncheh; Zahra Pournamdar; Hamid Salehiniya
Journal:  Asian Pac J Cancer Prev       Date:  2016

3.  Vascular proliferation is a prognostic factor in breast cancer.

Authors:  Jarle B Arnes; Ingunn M Stefansson; Oddbjørn Straume; Jan P Baak; Per E Lønning; William D Foulkes; Lars A Akslen
Journal:  Breast Cancer Res Treat       Date:  2011-09-27       Impact factor: 4.872

4.  Comparison of Microvessel Density with Prognostic Factors in Invasive Ductal Carcinomas of the Breast.

Authors:  Ebru Şener; Sare Şipal; Cemal Gündoğdu
Journal:  Turk Patoloji Derg       Date:  2016

5.  Tumor neoangiogenesis by CD31 and CD105 expression evaluation in breast carcinoma tissue microarrays.

Authors:  Colette Charpin; Jean-Philippe Dales; Stéphane Garcia; Séverine Carpentier; Amina Djemli; Lucile Andrac; Marie-Noëlle Lavaut; Claude Allasia; Pascal Bonnier
Journal:  Clin Cancer Res       Date:  2004-09-01       Impact factor: 12.531

6.  The analysis of CD34 antigen immunoreactivity level in invasive ductal breast cancer with respect to the presence of lymph node metastases.

Authors:  Tadeusz J Popiela; Jerzy Sikora; Marek Klimek; Pawel Basta; Tomasz Niemiec; Jan Dobrogowski; Agnieszka Kotlarz; Lucyna Rudnicka-Sosin; Magdalena Dutsch-Wicherek
Journal:  Neuro Endocrinol Lett       Date:  2008-08       Impact factor: 0.765

Review 7.  CD105 is important for angiogenesis: evidence and potential applications.

Authors:  Sarah E Duff; Chenggang Li; John M Garland; Shant Kumar
Journal:  FASEB J       Date:  2003-06       Impact factor: 5.191

8.  Prognostic value of microvessel density in invasive ductal carcinoma of the breast.

Authors:  Shinichi Tsutsui; Masazumi Kume; Shoichi Era
Journal:  Breast Cancer       Date:  2003       Impact factor: 4.239

9.  Immunohistochemical evaluation of the microvascular density through the expression of TGF-beta (CD 105/endoglin) and CD 34 receptors and expression of the vascular endothelial growth factor (VEGF) in oligodendrogliomas.

Authors:  Gabriel Corteze Netto; Cristina Birlem Bleil; Arlete Hilbig; Lígia Maria Barbosa Coutinho
Journal:  Neuropathology       Date:  2008-02       Impact factor: 1.906

10.  Angiogenesis in cancer of unknown primary: clinicopathological study of CD34, VEGF and TSP-1.

Authors:  Vasilis Karavasilis; Vasiliki Malamou-Mitsi; Evangelos Briasoulis; Elena Tsanou; Evangelia Kitsou; Haralambos Kalofonos; George Fountzilas; Theodore Fotsis; Nicholas Pavlidis
Journal:  BMC Cancer       Date:  2005-03-03       Impact factor: 4.430

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.